JanUmet Before Insulin Lantus In Eastern Population Evaluation Program (JUBILEE) In Type 2 Diabetic Patients
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of a new treatment regimen of metformin plus sitagliptin
(Janumet) followed by a long-acting basal insulin (Lantus) treatment compared to the usual
treatment regimen of metformin followed by sulfonylurea and intermediate-acting basal insulin
in Type 2 Diabetes Mellitus patients.